Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo
Titel:
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo
Auteur:
Briest, Franziska Koziolek, Eva J. Albrecht, Jakob Schmidt, Fränze Bernsen, Monique R. Haeck, Joost Kühl, Anja A. Sedding, Dagmar Hartung, Teresa Exner, Samantha Welzel, Martina Fischer, Christian Grötzinger, Carsten Brenner, Winfried Baum, Richard P. Grabowski, Patricia